Silverberg, Jonathan I., et al. “Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults With Moderate-to-Severe Atopic Dermatitis”. Acta Dermato-Venereologica, vol. 101, no. 11, Nov. 2021, p. adv00585, doi:10.2340/actadv.v101.307.